Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 15, 2025 $745.68 -1.15% $757.18 X 98.48% 0
Apr 15, 2025 Bearish $757.18 X 0
Apr 14, 2025 $718.27 -1.93% $754.35 X 95.22% 0
Apr 14, 2025 $741.25 +1.21% $754.35 V 98.26% 1
Apr 14, 2025 Bullish $754.35 V 1
Apr 11, 2025 $735.40 +2.01% $732.41 V 99.59% 5
Apr 11, 2025 $729.97 +1.26% $732.41 V 99.67% 5
Apr 11, 2025 Bearish $732.41 V 0
Apr 8, 2025 $735.88 +1.68% $726.24 V 98.67% 2
Apr 8, 2025 $731.32 +1.05% $726.24 V 99.30% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE